Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 6Phase 2 4Phase 1 3Phase NA 1Phase 3 1Phase 1/2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Genitourinary 1

Conditions

Brain Neoplasms 2Glioblastoma 1

Interventions

Temozolomide 147Radiotherapy 91Cyclophosphamide 53Magnetic Resonance Spectroscopy 43Radiation 42Bevacizumab 38Irinotecan 34Filgrastim 29Radiosurgery 27Specimen Handling 25Nivolumab 25Carboplatin 24Topotecan 23Etoposide 22fludarabine 20Surgical Procedures, Operative 20pembrolizumab 19Vorinostat 18Vincristine 18Melphalan 17Granulocyte Colony-Stimulating Factor 17sargramostim 15Peripheral Blood Stem Cell Transplantation 14Ipilimumab 14Drug Therapy 13temsirolimus 12Sirolimus 12Radiotherapy, Intensity-Modulated 12O(6)-benzylguanine 12Everolimus 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × fluciclovine F-18 × CNS × Clear all
NCT06048094 2026-05-20

FACILITATE

Baptist Health South Florida

Phase 1 Recruiting
46 enrolled
CNS

Brain Neoplasms

NCT04689048 2026-04-22

Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery

Baptist Health South Florida

Phase 1 Recruiting
20 enrolled
CNS

Brain Neoplasms

NCT03990285 2021-12-22

Axumin

Abramson Cancer Center at Penn Medicine

Phase 1 Completed
30 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡